Injectable Polyethylene Glycol Terminated Poly propylene fumarate / Acrylamide Biodegradable Materials for Cardiac Applications

Year 2008, Volume: 36 Issue: 4 , 283 - 290 , 01.12.2008

Bobby C. Kallukalam Mutu Jayabalan Vandana Sankar

https://izlik.org/JA49YY53XA

Abstract

Injectable and biodegradable hydrogel material based on polyethylene glycol terminated poly propylenefumarate PEG-PPF-PEG / acrylamide have been developed and evaluated for cardiac applications. The presentPEG-PPF-PEG resin undergoes fast setting with acrylamide with low exothermic temperature and mechanicalproperties equivalent to that of cardiac tissue. The chemically cross linked hydrogels undergo swelling in Ringer’ssolution prior to degradation. The present material are non cytotoxic to L-929 fibroblast and compatible with thecardiac fibroblast cells. Adhesion and proliferation of cardiac fibroblast cells has been appreciably good which is dueto surface reorganisation and generation of synergistic hydrophilic-hydrophobic surface

Keywords

Injectable and biodegradable hydrogel , Polyethylene glycol terminated pol propylene fumarate /acrylamide , Fast

References

• 1. K.T. Shalumon and M. Jayabalan, Studies on biodegradation of crosslinked hydroxyl terminated poly(propylene fumarate) and formation of scaffold for orthopedic applications J. Mater. Sci. Mater. in Medicine, (online: 27 June 2008).
• 2. V.Thomas, M.Jayabalan, In vivo biocompatibility and biodurability of a novel virtually crosslinked high flex-life aliphatic polyurethane urea for fabrication of heart valve J. Biomed.Mat. Res.-Part A, (Online 22, Apr, 2008).
• 3. R.R.Nair and P.N.Gupta, Journal of Tissue Engineering Methods. 11 (1988) 211.
• 4. Federal Regulations, Title 21,3 (April1, 2002) 325.
• 5. W.R. Gombotz, W. Guanghui, T.A. Horbett and A.S. Hoffman, J. Biomed. Mater. Res. 25 (1991) 1547.
• 6. E.A. Merril and E.W. Salzman, ASAIO J. 6 (1983) 60.
• 7. P.M. Edwards, Biochem. Pharmacol., 24 (1975) 1277.
• 8. M.J. Miller, D.E. Carter and I.G. Sipes, Toxicol. Appl. Pharmacol., 63 (1982) 36.
• 9. M.I. Kaplan, S.D. Murphy and F.H. Gilles, Toxicol. Appl. Pharmacol., 24 (1973) 564.
• 10. L.H. Christensen, V.B. Breiting, A. Aasted, A. Jorgensen and I. Kebuladge, Plastic & Reconstructive Surgery. 111 (6) (2003) 1883.
• 11.N. Yoshimatsu, J. Kyoto Pref. Med. Univ., 64 (1958) 553.
• 12. P.B. Van Wardem, A. Hogt, J. Bengeling, J. Feijen, A. Bantis, J.P. Detmers and W.G. Van Akan, Biomaterials., 8 (1987) 323.
• 13. T. Koyano, N.Minoura, M.Nagura and K. Kobayashi, J. Biomed. Mater. Res., 39 (1998) 486.